Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to measure the activation of the vagus nerve and the side effects of vagus nerve stimulation (VNS) (neck muscle contractions, changes in heart rate) across a range of stimulation parameters typically used in VNS therapy for epilepsy (pulse durations, pulse amplitudes, pulse repetition rates). This mapping of the parameter space may inform future device programming to improve electrical activation of the vagus nerve and/or to reduce side effects, and it may be used for validation of computational models. The study will recruit adult participants with epilepsy who are undergoing surgery either for an initial implant of a VNS device or for replacement of the implanted pulse generator (IPG) due to battery depletion. During surgery, the study will involve stimulating the vagus nerve via the standard implanted clinical VNS electrodes over a range of stimulation parameters while recording the activity of the vagus nerve (electroneurogram (ENG)), electromyogram (EMG) response of neck/throat muscles, and the heart rate (electrocardiogram (EKG)). Stimulation parameters will be within the ranges used for clinical therapy and below limits established for non-damaging electrical stimulation.


Clinical Trial Description

This study will recruit adult participants with epilepsy who are undergoing planned surgery either for an initial implant of a vagus nerve stimulation (VNS) device or for replacement of their VNS implanted pulse generator (IPG) due to battery depletion. The primary study goals are to measure the activation of the vagus nerve and the side effects of vagus nerve stimulation (neck muscle contractions, changes in heart rate) across a range of stimulation parameters typically used in VNS therapy for epilepsy. This mapping of the parameter space may inform future device programming to improve electrical activation of the vagus nerve and/or to reduce side effects. All study participants will be assigned to a single study group and will complete the same study procedures. The research study will take place during VNS surgery. For participants undergoing a first VNS implant surgery, once the vagus nerve is exposed and before placing the VNS electrodes, the investigators may image the nerve with ultrasound. Mapping of the parameter space will then occur after placement of the cuff electrodes around the cervical vagus nerve for participants undergoing a first VNS implant surgery or removal of the IPG with the depleted battery for patients undergoing IPG replacement surgery. Temporary sterile extension wires will connect the implanted VNS electrode to the research stimulation system. Research procedures will involve stimulating the vagus nerve through the standard implanted clinical VNS electrodes over a range of stimulation parameters. At the same time, the investigators will record how changes in stimulation affect the activity of the vagus nerve (measured by electroneurogram (ENG)), the response of the neck and throat muscles (by electromyogram (EMG)) and the heart rate (by electrocardiogram (EKG)). Several stimulation trials will be conducted with different VNS parameters (pulse duration, pulse amplitude, and pulse repetition rate) delivered in randomized order. Stimulation parameters will be within the ranges used for clinical therapy and will not exceed those that produce a 25% reduction in heart rate. Measurements will be made during 10 to 60 second trials, in which stimulation will be off for the first section (baseline), on for the second section (responses to stimulation), and off for the final section (recovery). The stimulus waveform will be a charge-balanced biphasic pulse, with values of charge density (D) limited to values below the nondamaging limits that are well-established in literature. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05395026
Study type Interventional
Source Duke University
Contact
Status Enrolling by invitation
Phase N/A
Start date November 28, 2022
Completion date April 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT04595513 - Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants Phase 1/Phase 2
Completed NCT02909387 - Adapting Project UPLIFT for Blacks in Georgia N/A
Completed NCT05552924 - Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients N/A
Terminated NCT01668654 - Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS Phase 3
Not yet recruiting NCT05068323 - Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients N/A
Completed NCT03994718 - Creative Arts II Study N/A
Recruiting NCT04076449 - Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Completed NCT00782249 - Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Recruiting NCT05101161 - Neurofeedback Using Implanted Deep Brain Stimulation Electrodes N/A
Active, not recruiting NCT06034353 - Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients N/A
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Not yet recruiting NCT05559060 - Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
Completed NCT02646631 - Behavioral and Educational Tools to Improve Epilepsy Care N/A
Completed NCT02977208 - Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use Phase 4
Completed NCT02952456 - Phenomenological Approach of Epilepsy in Patients With Epilepsy
Recruiting NCT02539134 - TAK-935 Multiple Rising Dose Study in Healthy Participants Phase 1
Terminated NCT02757547 - Transcranial Magnetic Stimulation for Epilepsy N/A
Completed NCT02491073 - Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL) N/A
Completed NCT02970396 - Self-management for People With Epilepsy and a History of Negative Health Events N/A